General Information of Drug (ID:
DR1924) |
Drug Name |
SRT-647
|
Synonyms |
N-ribosyl-nicotinamide; N-ribosylnicotinamide; SRT 647; SRT-647; SRT647; beta-nicotinamide D-riboside; nicotinamide ribonucleoside; nicotinamide ribose; nicotinamide riboside; nicotinamide-beta-riboside; ribosylnicotinamide; 0I8H2M0L7N; 1-(beta-D-Ribofuranosyl)nicotinamide; 1341-23-7; 3-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium; 3-carbamoyl-1-beta-D-ribofuranosylpyridinium; AC1L98BO; CHEBI:15927; Pyridinium, 3-(aminocarbonyl)-1-beta-D-ribofuranosyl-; UNII-0I8H2M0L7N
|
Indication |
Mitochondrial myopathy
[ICD11: 8C73]
|
Phase 1
|
[]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
255.25 |
Topological Polar Surface Area |
117 |
Heavy Atom Count |
18 |
Rotatable Bond Count |
3 |
Hydrogen Bond Donor Count |
4 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 439924
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0SI9L
- Formula
- C11H15N2O5+
- Canonical SMILES
- C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N
- InChI
- 1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1
- InChIKey
- JLEBZPBDRKPWTD-TURQNECASA-O
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.